top of page
IMG_8015.JPG

Leading the Future in Point of Care Diagnostics

Pitch Deck_JDS_v3.pptx.pdf.png

Introducing the OcuCheck™ Biosensor

The OcuCheck is a revolutionary point of care device designed to provide unparalled precision in tear fluid analysis. 

​

The core technology of our sensor allows for superior data analytics to guide disease diagnosis and management.

 

Our platform technology delivers a quantitative, immediate result.

​

qUANTITATIVE dIAGNOSTICS

A Quantitative Measurement Tear Fluid Biomarkers Such As MMP-9 And Lacritin 

pERSONALIZED treatment solutions

An Objective Measurement Can Be Used To Standardize And Classify Different Forms Of Dry Eye Disease. 

INNOVATIVE PLATFORM TECHNOLOGY

Multi-Platform Technology Can Pivot To Detect Biomarkers For Systemic Disease 

About Us

ABOUT US

ADVANCING TEAR FLUID ANALYTICS

Our company is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye and systemic disease. Our primary focus is to provide an objective measurement of tear fluid biomarkers to standardize treatment solutions not only for dry eye but for systemic disease. We are an innovative tear fluid analytic company enabling detection of hard to diagnose diseases by collecting and analyzing tear fluid in a non-invasive way. 

OUR FOCUS

IMPROVING ACCESS TO CARE

Working together to seamlessly translate innovations from the laboratory to clinical practice, elevating personalized medicine through the integration of cutting-edge technology into clinical settings. 

​

Our current research and development efforts are centered on expanding the capabilities of the OcuCheck Biosensor to screen, analyze, and manage a range of eye and systemic disease. 

Our Services

"Dry Eye is under-diagnosed and patients are suffering."

Deepinder Dhaliwal, MD L. Ac, University of Pittsburgh Medical Center, Pittsburgh, PA 

Products

INNOVATION

The OcuCheck is a point-of-care device that uses a specialized electrochemical sensor with proprietary coatings to measure specific biomarkers present in the tear fluid. Currently, the OcuCheck is the only device that can simultaneously measure MMP-9 and tear film osmolarity in one device. It is also one of the most accurate devices for quantitative measurement of MMP-9.

​

 The OcuCheck device is lightweight, portable, and durable so that it can be used outside of a clinical setting.

Newsroom

NEWSROOM

image.png
3VFmPMQ__400x400.jpg
896393f7-b9fa-49de-bc9c-ef8efa613a29_300_300_100.PNG
eyecelerator_feat-img.jpg.webp
1519856631389.jpeg
alh-logo-292x300.png
62bccf3dc3f4e4f1d266d6d4_published-in-scientific-reports.png
JVn3Pe_s_400x400.png

Connect With Us

InnSight Technology

100 S Jackson Ave

Pittsburgh, PA 15202

Thanks for submitting!

bottom of page